Skip to main content
Erschienen in: International Journal of Colorectal Disease 9/2021

21.05.2021 | Original Article

Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world study

verfasst von: Omar Abdel-Rahman, Patricia A. Tang, Sheryl Koski

Erschienen in: International Journal of Colorectal Disease | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To assess the patterns of hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy and to identify high-risk groups that may benefit from more careful monitoring in a real-world, population-based context.

Methods

This is a population-based study using linked administrative databases from the province of Alberta, Canada. Any events of hospitalization among patients with non-metastatic colon cancer undergoing upfront surgery followed by adjuvant chemotherapy were reviewed. Multivariable logistic regression analysis was used to examine factors associated with risk of hospitalization, and the impact of hospitalization on overall survival was assessed through Kaplan–Meier estimates and Multivariable Cox regression analysis.

Results

A total of 2257 patients were considered eligible and were included in the current analysis, including 483 patients (21.4%) who were hospitalized within 6 months of the start of adjuvant chemotherapy, and 1774 patients (78.6%) who were not. The following factors were associated with a higher hospitalization risk: older age (OR: 1.02; 95% CI 1.01–1.03), higher comorbidity (OR: 1.48; 95% CI 1.31–1.67), women (OR for men versus women: 0.79; 95% CI 0.64–0.98), living in the North zone (OR for Edmonton zone versus North zone: 0.60; 95% CI 0.42–0.87), and CAPOX chemotherapy (OR for CAPOX versus FOLFOX: 1.50; 95% CI 1.12–2.00). Patients with a history of hospitalization during adjuvant chemotherapy had a worse overall survival compared to patients who were not hospitalized (P < 0.001).

Conclusion

In this study, one out of five colon cancer patients were hospitalized during adjuvant chemotherapy. Older individuals, women, those with higher comorbidity, and those receiving adjuvant CAPOX were more likely to be hospitalized.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18(1):e87–e95CrossRef Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18(1):e87–e95CrossRef
2.
Zurück zum Zitat Doubeni CA (2019) Early-onset colorectal cancer: what reported statistics can and cannot tell us and their implications. Cancer 125(21):3706–3708CrossRef Doubeni CA (2019) Early-onset colorectal cancer: what reported statistics can and cannot tell us and their implications. Cancer 125(21):3706–3708CrossRef
3.
Zurück zum Zitat Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ (2020) Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open 3(1):e1920407CrossRef Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ (2020) Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open 3(1):e1920407CrossRef
4.
Zurück zum Zitat Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC et al (2019) Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ 367:l5515CrossRef Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC et al (2019) Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ 367:l5515CrossRef
5.
Zurück zum Zitat Virostko J, Capasso A, Yankeelov TE, Goodgame B (2019) Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004–2015. Cancer 125(21):3828–3835CrossRef Virostko J, Capasso A, Yankeelov TE, Goodgame B (2019) Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004–2015. Cancer 125(21):3828–3835CrossRef
6.
Zurück zum Zitat Mannucci A, Zuppardo RA, Rosati R, Leo MD, Perea J, Cavestro GM (2019) Colorectal cancer screening from 45 years of age: thesis, antithesis and synthesis. World J Gastroenterol 25(21):2565–2580CrossRef Mannucci A, Zuppardo RA, Rosati R, Leo MD, Perea J, Cavestro GM (2019) Colorectal cancer screening from 45 years of age: thesis, antithesis and synthesis. World J Gastroenterol 25(21):2565–2580CrossRef
7.
Zurück zum Zitat O’Sullivan DE, Hilsden RJ, Ruan Y, Forbes N, Heitman SJ, Brenner DR (2020) The incidence of young-onset colorectal cancer in Canada continues to increase. Cancer Epidemiol 69:101828CrossRef O’Sullivan DE, Hilsden RJ, Ruan Y, Forbes N, Heitman SJ, Brenner DR (2020) The incidence of young-onset colorectal cancer in Canada continues to increase. Cancer Epidemiol 69:101828CrossRef
8.
Zurück zum Zitat Abdel-Rahman O (2019) Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int J Clin Oncol 24(12):1582–1587CrossRef Abdel-Rahman O (2019) Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int J Clin Oncol 24(12):1582–1587CrossRef
9.
Zurück zum Zitat Giryes A, Oweira H, Mannhart M, Abdel-Rahman O (2018) Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer: a patient-level pooled analysis of two clinical trials. Expert Rev Gastroenterol Hepatol 12(8):843–848CrossRef Giryes A, Oweira H, Mannhart M, Abdel-Rahman O (2018) Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer: a patient-level pooled analysis of two clinical trials. Expert Rev Gastroenterol Hepatol 12(8):843–848CrossRef
10.
Zurück zum Zitat Batra A, Rigo R, Sheka D, Cheung WY (2020) Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer. World J Gastrointest Oncol 12(6):604–618CrossRef Batra A, Rigo R, Sheka D, Cheung WY (2020) Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer. World J Gastrointest Oncol 12(6):604–618CrossRef
11.
Zurück zum Zitat Batra A, Kong S, Cheung WY (2020) Eligibility of real-world patients with stage II and III colon cancer for adjuvant chemotherapy trials. Clin Colorectal Cancer 19(4):e226–e234CrossRef Batra A, Kong S, Cheung WY (2020) Eligibility of real-world patients with stage II and III colon cancer for adjuvant chemotherapy trials. Clin Colorectal Cancer 19(4):e226–e234CrossRef
12.
Zurück zum Zitat Andersson Y, Bergkvist L, Frisell J, de Boniface J (2019) Do clinical trials truly mirror their target population? an external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer. Breast Cancer Res Treat 177(2):469–475CrossRef Andersson Y, Bergkvist L, Frisell J, de Boniface J (2019) Do clinical trials truly mirror their target population? an external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer. Breast Cancer Res Treat 177(2):469–475CrossRef
13.
Zurück zum Zitat Surveillance & Reporting (2020) Alberta cancer registry/electronic medical records. cancer research & analytics, cancer care Alberta, Alberta health services Surveillance & Reporting (2020) Alberta cancer registry/electronic medical records. cancer research & analytics, cancer care Alberta, Alberta health services
14.
Zurück zum Zitat Abdel-Rahman O, Karachiwala H (2019) Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials. Int J Colorectal Dis 34(10):1741–1747CrossRef Abdel-Rahman O, Karachiwala H (2019) Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials. Int J Colorectal Dis 34(10):1741–1747CrossRef
15.
Zurück zum Zitat Abdel-Rahman O, Ahmed O (2019) Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer. Int J Colorectal Dis 34(4):675–680CrossRef Abdel-Rahman O, Ahmed O (2019) Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer. Int J Colorectal Dis 34(4):675–680CrossRef
16.
Zurück zum Zitat Abdel-Rahman O (2019) Impact of sex on chemotherapy toxicity and efficacy among patients with metastatic colorectal cancer: pooled analysis of 5 randomized trials. Clin Colorectal Cancer 18(2):110–5.e2CrossRef Abdel-Rahman O (2019) Impact of sex on chemotherapy toxicity and efficacy among patients with metastatic colorectal cancer: pooled analysis of 5 randomized trials. Clin Colorectal Cancer 18(2):110–5.e2CrossRef
17.
Zurück zum Zitat Özdemir BC, Csajka C, Dotto GP, Wagner AD (2018) Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology. J Clin Oncol 36(26):2680–2683CrossRef Özdemir BC, Csajka C, Dotto GP, Wagner AD (2018) Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology. J Clin Oncol 36(26):2680–2683CrossRef
18.
Zurück zum Zitat Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P et al (2021) Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol 39(7):734–747CrossRef Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P et al (2021) Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol 39(7):734–747CrossRef
19.
Zurück zum Zitat Abdel-Rahman O (2021) Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study. J Comp Eff Res 10(2):119–126CrossRef Abdel-Rahman O (2021) Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study. J Comp Eff Res 10(2):119–126CrossRef
20.
Zurück zum Zitat Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW et al (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23(3):687–694CrossRef Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW et al (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23(3):687–694CrossRef
21.
Zurück zum Zitat McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson III AB et al (2002) Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 94(15):1160–1167CrossRef McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson III AB et al (2002) Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 94(15):1160–1167CrossRef
23.
Zurück zum Zitat Cheung WY, Shi Q, O’Connell M, Cassidy J, Blanke CD, Kerr DJ et al (2013) The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database. Clin Colorectal Cancer 12(3):179–187CrossRef Cheung WY, Shi Q, O’Connell M, Cassidy J, Blanke CD, Kerr DJ et al (2013) The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database. Clin Colorectal Cancer 12(3):179–187CrossRef
Metadaten
Titel
Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world study
verfasst von
Omar Abdel-Rahman
Patricia A. Tang
Sheryl Koski
Publikationsdatum
21.05.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 9/2021
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-021-03952-4

Weitere Artikel der Ausgabe 9/2021

International Journal of Colorectal Disease 9/2021 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.